10-K Filing

Silo Pharma, Inc. CIK: 1514183 FY 2018

Filing Information

Form Type	10-K
Accession Number	`0001213900-19-005789`
Period End Date	20181231
Filing Date	20190404
Fiscal Year	2018
Fiscal Period	FY
XBRL Instance	ptci-20181231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 36 Cash Flow Statement 54 Stockholders Equity 17

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Equity investments cost	`InvestmentOwnedAtCost`	$45.34K	USD	Point-in-time
Equity investments cost	`InvestmentOwnedAtCost`	$876.36K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares designated	`TemporaryEquitySharesDesignated`	1.00M	shares	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares designated	`TemporaryEquitySharesDesignated`	1.00M	shares	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares issued	`TemporaryEquitySharesIssued`	4,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$294.59K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$579.21K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$336.68K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares issued	`TemporaryEquitySharesIssued`	4,000.00	shares	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares outstanding	`TemporaryEquitySharesOutstanding`	4,000.00	shares	Point-in-time
Equity investments, at fair value (cost of $45,336 and $876,358 at December 31, 2018 and 2017, respectively)	`EquitySecuritiesFvNi`	$1.32M	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares outstanding	`TemporaryEquitySharesOutstanding`	4,000.00	shares	Point-in-time
Equity investments, at fair value (cost of $45,336 and $876,358 at December 31, 2018 and 2017, respectively)	`EquitySecuritiesFvNi`	$215.53K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, per share redemption value	`TemporaryEquityRedemptionPricePerShare`	$100.00	USD	Point-in-time
Equity investments, at cost	`EquityMethodInvestmentAggregateCost`	-	USD	Point-in-time
Equity investments, at cost	`EquityMethodInvestmentAggregateCost`	$12.77K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, per share redemption value	`TemporaryEquityRedemptionPricePerShare`	$100.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$26.57K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$34.03K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Inventory	`InventoryNet`	$26.97K	USD	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$625.98K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$1.64M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	23.42M	shares	Point-in-time
Note receivable	`NotesAndLoansReceivableNetNoncurrent`	$200.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	50.08M	shares	Point-in-time
Note receivable	`NotesAndLoansReceivableNetNoncurrent`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	23.42M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	50.08M	shares	Point-in-time
Intangible asset	`IntangibleAssetsNetExcludingGoodwill`	-	USD	Point-in-time
Intangible asset	`IntangibleAssetsNetExcludingGoodwill`	$29.44K	USD	Point-in-time
Total Other Assets	`AssetsNoncurrent`	-	USD	Point-in-time
Total Other Assets	`AssetsNoncurrent`	$229.44K	USD	Point-in-time
Total Assets	`Assets`	$855.42K	USD	Point-in-time
Total Assets	`Assets`	$1.64M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$38.34K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$25.63K	USD	Point-in-time
Insurance finance loan	`InsuranceFinanceLoanCurrent`	-	USD	Point-in-time
Insurance finance loan	`InsuranceFinanceLoanCurrent`	$22.34K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$38.34K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$47.98K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, 1,000,000 shares designated; 4,000 shares issued and outstanding at December 31, 2018 and 2017 ($100 per share redemption and liquidation value)	`TemporaryEquityCarryingAmountAttributableToParent`	$400.00K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, 1,000,000 shares designated; 4,000 shares issued and outstanding at December 31, 2018 and 2017 ($100 per share redemption and liquidation value)	`TemporaryEquityCarryingAmountAttributableToParent`	$400.00K	USD	Point-in-time
Preferred stock, $0.0001 par value, 5,000,000 shares authorized	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 5,000,000 shares authorized	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 23,417,450 and 50,082,441 shares issued and outstanding at December 31, 2018 and 2017, respectively	`CommonStockValue`	$5.01K	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 23,417,450 and 50,082,441 shares issued and outstanding at December 31, 2018 and 2017, respectively	`CommonStockValue`	$2.34K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.87M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.05M	USD	Point-in-time
Accumulated net investment loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-470.39K	USD	Point-in-time
Accumulated net investment loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	-	USD	Point-in-time
Accumulated undistributed net realized loss on investments	`AccumulatedUndistributedNetRealizedLossOnInvestments`	$-651.53K	USD	Point-in-time
Accumulated undistributed net realized loss on investments	`AccumulatedUndistributedNetRealizedLossOnInvestments`	-	USD	Point-in-time
Unrealized appreciation on investments	`UnrealizedAppreciationOnInvestments`	-	USD	Point-in-time
Unrealized appreciation on investments	`UnrealizedAppreciationOnInvestments`	$448.87K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	-	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.64M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$407.44K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$1.20M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$846.51K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$855.42K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$1.64M	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
REVENUES	`Revenues`	-	USD	Annual
REVENUES	`Revenues`	-	USD	Annual
Compensation expense	`ShareBasedCompensation`	$177.50K	USD	Annual
Compensation expense	`ShareBasedCompensation`	$145.00K	USD	Annual
Professional fees	`ProfessionalFees`	$203.56K	USD	Annual
Professional fees	`ProfessionalFees`	$185.29K	USD	Annual
Insurance expense	`GeneralInsuranceExpense`	$35.60K	USD	Annual
Insurance expense	`GeneralInsuranceExpense`	$35.20K	USD	Annual
Bad debt expense, net of recovery	`ProvisionForDoubtfulAccounts`	$35.00K	USD	Annual
Bad debt expense, net of recovery	`ProvisionForDoubtfulAccounts`	$62.91K	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$76.08K	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$29.56K	USD	Annual
Impairment loss	`AssetImpairmentCharges`	-	USD	Annual
Impairment loss	`AssetImpairmentCharges`	$99.41K	USD	Annual
Total operating expenses	`OperatingExpenses`	$490.87K	USD	Annual
Total operating expenses	`OperatingExpenses`	$594.24K	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-490.87K	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-594.24K	USD	Annual
Interest income	`InvestmentIncomeNet`	$20.48K	USD	Annual
Interest income	`InvestmentIncomeNet`	$4.22K	USD	Annual
Net realized loss on equity investments (non-controlled/non-affiliated investments)	`RealizedGainLossOnEquityInvestments`	$-85.17K	USD	Annual
Net realized loss on equity investments (non-controlled/non-affiliated investments)	`RealizedGainLossOnEquityInvestments`	$-100.76K	USD	Annual
Net unrealized (loss) gain on equity investments (non-controlled/non-affiliated investments)	`UnrealizedGainLossOnEquityInvestments`	$-278.68K	USD	Annual
Net unrealized (loss) gain on equity investments (non-controlled/non-affiliated investments)	`UnrealizedGainLossOnEquityInvestments`	$912.09K	USD	Annual
Total other (expense) income	`NonoperatingIncomeExpense`	$-375.22K	USD	Annual
Total other (expense) income	`NonoperatingIncomeExpense`	$847.41K	USD	Annual
NET (LOSS) INCOME	`NetIncomeLoss`	$-969.46K	USD	Annual
NET (LOSS) INCOME	`NetIncomeLoss`	$356.54K	USD	Annual
Basic	`EarningsPerShareBasic`	$0.01	USD	Annual
Basic	`EarningsPerShareBasic`	$-0.02	USD	Annual
Diluted	`EarningsPerShareDiluted`	$-0.02	USD	Annual
Diluted	`EarningsPerShareDiluted`	$0.01	USD	Annual
Basic	`WeightedAverageNumberOfSharesIssuedBasic`	49.10M	shares	Annual
Basic	`WeightedAverageNumberOfSharesIssuedBasic`	50.08M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	52.08M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	49.10M	shares	Annual

Cash Flow Statement 54 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`NetIncomeLoss`	$-969.46K	USD	Annual
Net (loss) income	`NetIncomeLoss`	$356.54K	USD	Annual
Amortization	`AdjustmentForAmortization`	-	USD	Annual
Amortization	`AdjustmentForAmortization`	$17.55K	USD	Annual
Impairment loss	`AssetImpairmentCharges`	-	USD	Annual
Impairment loss	`AssetImpairmentCharges`	$99.41K	USD	Annual
Net realized loss on equity investments	`RealizedInvestmentGainsLosses`	$-85.17K	USD	Annual
Net realized loss on equity investments	`RealizedInvestmentGainsLosses`	$-100.76K	USD	Annual
Net unrealized loss (gain) on equity investments	`UnrealizedGainLossOnInvestments`	$912.09K	USD	Annual
Net unrealized loss (gain) on equity investments	`UnrealizedGainLossOnInvestments`	$-278.68K	USD	Annual
Proceeds from sale of equity investments	`GainLossOnSaleOfInvestments`	$-727.50K	USD	Annual
Proceeds from sale of equity investments	`GainLossOnSaleOfInvestments`	$-157.57K	USD	Annual
Bad debt expense, net of recovery	`ProvisionForDoubtfulAccounts`	$35.00K	USD	Annual
Bad debt expense, net of recovery	`ProvisionForDoubtfulAccounts`	$62.91K	USD	Annual
Decrease in prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-22.89K	USD	Annual
Decrease in prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-408.00	USD	Annual
Increase in interest receivable	`IncreaseDecreaseInAccruedInterestReceivableNet`	$20.36K	USD	Annual
Increase in interest receivable	`IncreaseDecreaseInAccruedInterestReceivableNet`	-	USD	Annual
Increase in inventory	`IncreaseDecreaseInInventories`	$26.97K	USD	Annual
Increase in inventory	`IncreaseDecreaseInInventories`	-	USD	Annual
Decrease in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-12.71K	USD	Annual
Decrease in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-14.76K	USD	Annual
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-284.62K	USD	Annual
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$272.64K	USD	Annual
Cash discbursements related to notes receivable	`PaymentsToAcquireNotesReceivable`	-	USD	Annual
Cash discbursements related to notes receivable	`PaymentsToAcquireNotesReceivable`	$250.00K	USD	Annual
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-250.00K	USD	Annual
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	-	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$24.50K	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Redemption of common stock	`CommonStockRedemptionAmount`	-	USD	Annual
Redemption of common stock	`CommonStockRedemptionAmount`	$2.87K	USD	Annual
Repayment of insurance finance loan	`RepaymentOfInsuranceFinanceLoan`	$2.18K	USD	Annual
Repayment of insurance finance loan	`RepaymentOfInsuranceFinanceLoan`	-	USD	Annual
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$19.45K	USD	Annual
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	-	USD	Annual
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS:	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$42.09K	USD	Annual
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS:	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-284.62K	USD	Annual
CASH AND CASH EQUIVALENTS - beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$294.59K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$579.21K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$336.68K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - end of year	`CashAndCashEquivalentsAtCarryingValue`	$294.59K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - end of year	`CashAndCashEquivalentsAtCarryingValue`	$579.21K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - end of year	`CashAndCashEquivalentsAtCarryingValue`	$336.68K	USD	Point-in-time
Interest	`InterestPaidNet`	-	USD	Annual
Interest	`InterestPaidNet`	-	USD	Annual
Income taxes	`IncomeTaxesPaidNet`	-	USD	Annual
Income taxes	`IncomeTaxesPaidNet`	-	USD	Annual
Interest receivable converted into equity investments	`InterestReceivableConvertedIntoInvestments`	$16.00K	USD	Annual
Interest receivable converted into equity investments	`InterestReceivableConvertedIntoInvestments`	-	USD	Annual
Common stock issued for acquisition of intangible assets and prepaid expenses	`CommonStockIssuedForAcquisitionOfIntangibleAssetsAndPrepaidExpenses`	$152.24K	USD	Annual
Common stock issued for acquisition of intangible assets and prepaid expenses	`CommonStockIssuedForAcquisitionOfIntangibleAssetsAndPrepaidExpenses`	-	USD	Annual
Increase in prepaid expenses and accrued expenses for insurance finance loan	`IncreaseInPrepaidExpensesAndAccruedExpensesForInsuranceFinanceLoan`	-	USD	Annual
Increase in prepaid expenses and accrued expenses for insurance finance loan	`IncreaseInPrepaidExpensesAndAccruedExpensesForInsuranceFinanceLoan`	$24.52K	USD	Annual

Stockholders Equity 17 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$407.44K	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.20M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$846.51K	USD	Point-in-time
Net realized loss on investments	`AccumulatedUndistributedNetRealizedGainLossOnInvestments`	$-85.17K	USD	Annual
Net unrealized gain on investments	`UnrealizedAppreciationOnInvestment`	$912.09K	USD	Annual
Common stock issued for asset acquisition	`StockIssuedDuringPeriodValueAcquisitions`	$24.50K	USD	Point-in-time
Common stock issued for asset acquisition	`StockIssuedDuringPeriodValueAcquisitions`	$152.24K	USD	Annual
Common stock issued for cash	`StockIssuedDuringPeriodValueNewIssues`	$24.50K	USD	Annual
Common stock repurchased for cash and cancelled	`StockRepurchasedDuringPeriodValue`	$2.87K	USD	Point-in-time
Common stock repurchased for cash and cancelled	`StockRepurchasedDuringPeriodValue`	$-2.87K	USD	Annual
Common stock repurchased for cash and cancelled, shares	`StockRepurchasedDuringPeriodShares`	28.73M	shares	Point-in-time
Adoption of corporation accounting related to terminiation of BDC status	`NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-969.46K	USD	Annual
Net loss	`NetIncomeLoss`	$356.54K	USD	Annual
Ending balance	`StockholdersEquity`	$407.44K	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.20M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$846.51K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.